• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反科学、疫苗犹豫与疫情应对:亚太传染病与免疫峰会要点

Antiscience, Vaccine Hesitancy, and Pandemic Responses: Highlights from the Asia Pacific Summit on Infectious Diseases and Immunization.

作者信息

Seth Ananta, Sevdalis Nick, Ismail Zulkifli, Hadinegoro Sri Rezeki, Larson Heidi J, Pangestu Tikki

机构信息

Asia-Pacific Immunization Coalition, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

出版信息

Vaccines (Basel). 2024 Nov 27;12(12):1336. doi: 10.3390/vaccines12121336.

DOI:10.3390/vaccines12121336
PMID:39771999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680259/
Abstract

The recent resurgence of mpox highlights the urgent need for rethinking vaccination strategies globally, underscored by the painful memories of past public health crises where delayed responses and inequitable vaccine distribution exacerbated the spread of infectious diseases. The inaugural APIC-ADVA Asia Pacific Summit on Infectious Diseases and Immunization, themed "Vaccination for All: Access, Confidence and Equity (ACE)", was held in Singapore from 31 October to 1 November 2023 in an attempt to present best practices and hard-won insights from battling COVID-19 and other pandemics in the Asia-Pacific region. This summit was co-convened by the Asia-Pacific Immunization Coalition (APIC) and Asia Dengue Voice and Action (ADVA). Local, regional, and international experts from academia, research and representatives from the Ministries of Health, the World Health Organization (WHO), and the International Vaccine Institute (IVI) participated in the 2 day summit. With more than 230 speakers and delegates from over 15 countries, and 4 symposia over 2 full days, the first APIC-ADVA Asia Pacific Summit on Infectious Diseases and Immunization highlighted critical issues affecting vaccine access, confidence, and equity, and emphasized the importance of safeguarding the world from existing infections and future pandemics through immunization.

摘要

猴痘近期的再度流行凸显了全球重新思考疫苗接种策略的紧迫性,过去公共卫生危机的惨痛记忆也强调了这一点,在这些危机中,反应迟缓以及疫苗分配不公加剧了传染病的传播。首届亚太感染病与免疫学会(APIC)-亚太登革热之声与行动组织(ADVA)亚太传染病与免疫峰会于2023年10月31日至11月1日在新加坡举行,主题为“全民接种:可及性、信心与公平性(ACE)”,旨在展示亚太地区抗击新冠疫情及其他大流行病过程中的最佳实践经验和来之不易的深刻见解。本次峰会由亚太免疫联盟(APIC)和亚太登革热之声与行动组织(ADVA)联合召集。来自学术界、研究领域的本地、区域和国际专家,以及来自各国卫生部、世界卫生组织(WHO)和国际疫苗研究所(IVI)的代表参加了为期两天的峰会。首届亚太感染病与免疫学会(APIC)-亚太登革热之声与行动组织(ADVA)亚太传染病与免疫峰会有来自15个以上国家的230多名发言者和代表参与,在整整两天内举办了4场专题研讨会,突出了影响疫苗可及性、信心和公平性的关键问题,并强调了通过免疫接种保护世界免受现有感染和未来大流行病侵害的重要性。

相似文献

1
Antiscience, Vaccine Hesitancy, and Pandemic Responses: Highlights from the Asia Pacific Summit on Infectious Diseases and Immunization.反科学、疫苗犹豫与疫情应对:亚太传染病与免疫峰会要点
Vaccines (Basel). 2024 Nov 27;12(12):1336. doi: 10.3390/vaccines12121336.
2
Proceedings of the 5th Asia Dengue Summit.第五届亚洲登革热峰会会议记录
Trop Med Infect Dis. 2023 Apr 19;8(4):231. doi: 10.3390/tropicalmed8040231.
3
Proceedings of the 6th Asia Dengue Summit, June 2023.第六届亚洲登革热峰会会议记录,2023 年 6 月。
PLoS Negl Trop Dis. 2024 Mar 29;18(3):e0012060. doi: 10.1371/journal.pntd.0012060. eCollection 2024 Mar.
4
ASVAC2019: 7th Asian Vaccine Conference.亚洲疫苗大会2019:第七届亚洲疫苗会议
Hum Vaccin Immunother. 2020 Jul 2;16(7):1476-1484. doi: 10.1080/21645515.2019.1695460. Epub 2020 Jan 6.
5
Exploring Future Pandemic Preparedness Through the Development of Preventive Vaccine Platforms and the Key Roles of International Organizations in a Global Health Crisis.通过开发预防性疫苗平台探索未来大流行防范以及国际组织在全球卫生危机中的关键作用。
Vaccines (Basel). 2025 Jan 10;13(1):56. doi: 10.3390/vaccines13010056.
6
ASVAC2022 : 8 Asian Vaccine Conference.ASVAC2022:第 8 届亚洲疫苗大会。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2165360. doi: 10.1080/21645515.2023.2165360. Epub 2023 Jan 19.
7
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.亚洲及太平洋地区轮状病毒疫苗使用情况综述:挑战与未来展望。
Expert Rev Vaccines. 2021 Dec;20(12):1499-1514. doi: 10.1080/14760584.2020.1853532. Epub 2021 Apr 20.
8
Vaccine Preventable Disease and Vaccine Hesitancy.疫苗可预防疾病与疫苗犹豫
Med Clin North Am. 2023 Nov;107(6):979-987. doi: 10.1016/j.mcna.2023.05.012. Epub 2023 Jul 11.
9
Report of the first Asia-Pacific influenza summit, Asia-Pacific Alliance for the Control of Influenza (APACI), Bangkok, 12-13 June 2012.2012 年 6 月 12 日至 13 日,在泰国曼谷举行的第一届亚太流感峰会报告,即亚太流感防治联盟(APACI)。
Influenza Other Respir Viruses. 2013 Nov;7(6):991-5. doi: 10.1111/irv.12133. Epub 2013 Jun 28.
10
The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise.第二届疫苗接种接受度研究网络会议(VARN2023):将免疫叙事转向以公平为中心和社区专业知识为中心。
Vaccine. 2024 Nov 14;42 Suppl 5:126027. doi: 10.1016/j.vaccine.2024.05.075. Epub 2024 Jun 18.

本文引用的文献

1
WHO Director-General declares mpox outbreak a public health emergency of international concern.世界卫生组织总干事宣布猴痘疫情构成“国际关注的突发公共卫生事件”。
Saudi Med J. 2024 Aug;45(9):1002-1003.
2
Vaccine Preventable Disease and Vaccine Hesitancy.疫苗可预防疾病与疫苗犹豫
Med Clin North Am. 2023 Nov;107(6):979-987. doi: 10.1016/j.mcna.2023.05.012. Epub 2023 Jul 11.
3
Erratum for the Review "Insights into dengue immunity from vaccine trials".《疫苗试验对登革热免疫的见解》综述勘误
Sci Transl Med. 2023 Aug 16;15(709):eadk1254. doi: 10.1126/scitranslmed.adk1254.
4
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.疫苗评估的全部价值(FVVA):评估和沟通疫苗投资和引入决策价值的框架。
BMC Med. 2023 Jul 4;21(1):229. doi: 10.1186/s12916-023-02929-0.
5
Promise of new malaria vaccines.
BMJ. 2022 Oct 14;379:o2462. doi: 10.1136/bmj.o2462.
6
Will anti-vaccine activism in the USA reverse global goals?美国的反疫苗运动是否会逆转全球目标?
Nat Rev Immunol. 2022 Sep;22(9):525-526. doi: 10.1038/s41577-022-00770-9.
7
Dengue Vaccines: An Update.登革热疫苗:最新进展。
BioDrugs. 2022 May;36(3):325-336. doi: 10.1007/s40259-022-00531-z. Epub 2022 May 24.
8
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.四价登革热疫苗在 4-16 岁健康儿童中的疗效:一项随机、安慰剂对照、3 期临床试验。
Lancet. 2020 May 2;395(10234):1423-1433. doi: 10.1016/S0140-6736(20)30414-1. Epub 2020 Mar 17.
9
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.四价登革热疫苗在健康儿童和青少年中的功效。
N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.
10
Dengue vaccine: WHO position paper, September 2018 - Recommendations.登革热疫苗:世卫组织立场文件,2018 年 9 月 - 建议。
Vaccine. 2019 Aug 14;37(35):4848-4849. doi: 10.1016/j.vaccine.2018.09.063. Epub 2018 Nov 10.